Abeona Therapeutics Inc. (ABEO) vs EyePoint Pharmaceuticals, Inc. (EYPT)
A side-by-side comparison of Abeona Therapeutics Inc. and EyePoint Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABEO
Abeona Therapeutics Inc.
$5.08HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
EYPT
EyePoint Pharmaceuticals, Inc.
$3.26HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
Total return — ABEO vs EYPT
growth of $100 · dividends reinvested · last 10yABEO -96.6% (-28.7%/yr)EYPT -86.8% (-18.3%/yr)EYPT compounded faster over this window
ABEO EYPT
ABEO vs EYPT: by the numbers
- •ABEO is the larger company ($289M vs $273M market cap).
- •Both run net losses; ABEO's is the smaller (-246.42% vs -10994.73% net margin).
- •Both shrank revenue over the past five years; ABEO's decline was smaller (-10.26% vs -41.05% CAGR).
Metrics side by side
Valuation
| Metric | ABEO | EYPT |
|---|---|---|
| P/S ratio | 11.33 | 97.85 |
| P/B ratio | 2.26 | 1.64 |
Profitability
| Metric | ABEO | EYPT |
|---|---|---|
| Gross margin | 73.68% | 93.41% |
| Operating margin | -1536.91% | -775.98% |
| Net margin | -246.42% | -10994.73% |
| ROE | -49.11% | -184.27% |
| ROIC | -49.76% | -170.19% |
Growth (annualized)
| Metric | ABEO | EYPT |
|---|---|---|
| Revenue CAGR (5Y) | -10.26% | -41.05% |
| Total return CAGR (5Y) | -26.46% | -21.68% |
Frequently asked
- Which has grown faster, ABEO or EYPT?
- Neither grew: over the past five years both shrank revenue, with ABEO's decline the smaller — ABEO at a -10.26% CAGR versus EYPT at -41.05%.
- How have ABEO and EYPT total returns compared?
- Over the past 10 years, ABEO delivered -29.45% and EYPT delivered -20.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.